Insulin aspart (Fiasp) til behandling av diabetes mellitus
The promising future of insulin therapy in diabetes mellitus | American Journal of Physiology-Endocrinology and Metabolism
Fiasp, Fiasp FlexTouch, Fiasp Penfill, - Felleskatalogen
Risiko for forveksling mellom insulinpennene Fiasp og Tresiba
Fiasp First Try – T1dLife
A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes | Diabetes Technology & Therapeutics
A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes | Diabetes Technology & Therapeutics
Fiasp, INN-insulin aspart
Penn State Health - Navigating Diabetes English version
Engineering biopharmaceutical formulations to improve diabetes management | Science Translational Medicine
Fiasp First Try – T1dLife
Engineering biopharmaceutical formulations to improve diabetes management | Science Translational Medicine
Fiasp First Try – T1dLife
Fiasp Novo Nordisk Penfill sylinderampuller - Felleskatalogen Pasientutgave
Beta receives FDA go-ahead for home trials of AI-guided bionic pancreas | Fierce Biotech
A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes | Diabetes Technology & Therapeutics
Risiko for forveksling mellom insulinpennene Fiasp og Tresiba
Risiko for forveksling mellom insulinpennene Fiasp og Tresiba
A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes | Diabetes Technology & Therapeutics
Mal blandekort (konsentrasjon)
Fiasp First Try – T1dLife
Biologiske legemidler og biotilsvarende legemidler
Fiasp Novo Nordisk FlexTouch ferdigfylt penn - Felleskatalogen Pasientutgave
